Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea

Roche

Status: Completed

Conditions: Gastroesophageal Junction Cancer; Gastric Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT02538562

ML25697

Details and patient eligibility

About

This study is designed to gather epidemiological data in Korea on HER2 incidence in gastric and gastroesophageal junction cancer as assessed by local laboratories in a real-life setting. No investigational products will be provided or evaluated.

Enrollment: 1,695 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Formalin-fixed, paraffin-embedded tumor tissue samples with histologically confirmed adenocarcinoma of the stomach or gastroesophageal junction with locally advanced, recurrent, and/or metastatic disease
• Sufficient invasive tumor tissue for HER2 evaluation, including surgical excision specimens or at least 6 to 8 available biopsies

Exclusion criteria

• None specified

Trial design

1,695 participants in 1 patient group

Study Population

Description:

Available tumor samples from patients with gastric or gastroesophageal junction cancer will be analyzed. No study visits or interventions are planned.